where the spine transitions from the less mobile thoracic segment to the more mobile lumbar segment, which is prone to stress concentration. As a result, less adjacent endplate pressure was favorable.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease. An intervention ...

The pilot trial in three adults with SMA showed that epidural spinal cord stimulation (SCS), which involves electrical stimulation of the sensory spinal nerves, can gradually reawaken functionally ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York City ...

Scientists report results from a promising new approach to treat the rare neurodegenerative disorder. Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before ...

The U.S. portion of the deal is expected to close in the first half of this year. “We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel ...

Opens in a new tab or window Epidural anesthetic or steroid injections, nerve blocks, and related interventions are commonly used to treat chronic back pain. This review found no solid evidence ...

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers for an undisclosed amount, the company announced Tuesday. The deal is ...

In a groundbreaking pilot study, researchers have found evidence that spinal cord stimulation could potentially benefit individuals with neurodegenerative diseases like spinal muscular atrophy (SMA).